We are live on ! Find out more
WTA

Washington Trust Advisors Portfolio holdings

AUM $1.24B
1-Year Est. Return 22.58%
This Fund
S&P 500
This Quarter Est. Return
-3.9%
1 Year Est. Return
+22.58%
3 Year Est. Return
+71.21%
5 Year Est. Return
10 Year Est. Return
AUM
$1.07B
AUM Growth
-$66M
Cap. Flow
-$12.6M
Cap. Flow %
-1.18%
Top 10 Hldgs %
32.76%
Holding
953
New
23
Increased
232
Reduced
236
Closed
43

Sector Composition

Rank Sector Weight
1 Healthcare 15.26%
2 Technology 13.77%
3 Industrials 11.22%
4 Consumer Discretionary 9%
5 Communication Services 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEO icon
51
Diageo
DEO
$49.4B
$5.58M 0.52%
32,870
-288
-0.9% -$51.6K
EW icon
52
Edwards Lifesciences
EW
$48.2B
$5.5M 0.52%
66,592
-2,586
-4% -$249K
KMI icon
53
Kinder Morgan
KMI
$70.3B
$5.04M 0.47%
302,632
-4,808
-2% -$85.5K
MTN icon
54
Vail Resorts
MTN
$5.6B
$4.94M 0.46%
22,929
-108
-0.5% -$24.6K
SCHP icon
55
Schwab US TIPS ETF
SCHP
$16.4B
$4.91M 0.46%
189,440
-9,438
-5% -$262K
ILMN icon
56
Illumina
ILMN
$29.2B
$4.78M 0.45%
25,761
-177
-0.7% -$35K
ISRG icon
57
Intuitive Surgical
ISRG
$130B
$4.69M 0.44%
25,041
+17
+0.1% +$3.65K
VOT icon
58
Vanguard Mid-Cap Growth ETF
VOT
$19.1B
$4.67M 0.44%
27,355
+2,438
+10% +$461K
FNDA icon
59
Schwab Fundamental US Small Company Index ETF
FNDA
$9.24B
$4.44M 0.42%
208,888
-8,746
-4% -$208K
VTI icon
60
Vanguard Total Stock Market ETF
VTI
$656B
$4.24M 0.4%
23,642
+164
+0.7% +$32.7K
WMT icon
61
Walmart Inc
WMT
$900B
$4.01M 0.38%
92,823
+468
+0.5% +$20.5K
KO icon
62
Coca-Cola
KO
$380B
$3.99M 0.37%
71,232
-3,312
-4% -$206K
NVDA icon
63
NVIDIA
NVDA
$4.77T
$3.9M 0.37%
321,160
+38,080
+13% +$602K
SCHE icon
64
Schwab Emerging Markets Equity ETF
SCHE
$12.3B
$3.68M 0.34%
+164,300
New +$4.06M
JPM icon
65
JPMorgan Chase
JPM
$950B
$3.66M 0.34%
35,064
+524
+2% +$60.1K
ADP icon
66
Automatic Data Processing
ADP
$106B
$3.26M 0.31%
14,406
-236
-2% -$55.7K
IEFA icon
67
iShares Core MSCI EAFE ETF
IEFA
$187B
$3.17M 0.3%
60,187
+1,798
+3% +$106K
VWO icon
68
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$2.91M 0.27%
79,649
-77,696
-49% -$3.15M
IWF icon
69
iShares Russell 1000 Growth ETF
IWF
$119B
$2.9M 0.27%
55,048
+4,020
+8% +$236K
ABT icon
70
Abbott
ABT
$187B
$2.87M 0.27%
29,680
DDD icon
71
3D Systems Corp
DDD
$412M
$2.81M 0.26%
352,496
-50,410
-13% -$518K
IBM icon
72
IBM
IBM
$214B
$2.69M 0.25%
22,675
-123
-0.5% -$16.1K
PG icon
73
Procter & Gamble
PG
$347B
$2.69M 0.25%
21,334
-129
-0.6% -$18.3K
CSCO icon
74
Cisco
CSCO
$456B
$2.56M 0.24%
63,915
-1,683
-3% -$74.7K
IWD icon
75
iShares Russell 1000 Value ETF
IWD
$82.2B
$2.48M 0.23%
18,197

Similar funds

Washington Trust Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Washington Trust Advisors held 953 positions worth $1.07B, down 5.8% from $1.13B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Washington Trust Advisors's Q3 2022 filing shows 23 new, 232 increased, 236 reduced and 43 closed positions. Its largest new stake was Schwab Emerging Markets Equity ETF: 164,300 shares worth $3.68M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $3.15M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Washington Trust Advisors's largest Q3 2022 buy was Schwab Emerging Markets Equity ETF: 164,300 shares worth $3.68M.
  • Washington Trust Advisors added most to Schwab Fundamental US Large Company Index ETF in Q3 2022, an estimated $3.19M increase.
  • Washington Trust Advisors's biggest Q3 2022 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $3.15M.
  • Washington Trust Advisors fully exited Neurocrine Biosciences in Q3 2022, selling an estimated $428K.
  • Washington Trust Advisors's ten largest holdings make up 33% of its $1.07B portfolio in Q3 2022.
  • Washington Trust Advisors opened 23 new positions and closed 43 in Q3 2022.
  • Washington Trust Advisors's portfolio value fell 5.8% quarter-over-quarter to $1.07B.

Based on Washington Trust Advisors's 13F filing for Q3 2022, filed 14 Oct 2022.